The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer
Open Access
- 20 January 2014
- journal article
- research article
- Published by Wiley in The Scientific World Journal
- Vol. 2014, 1-9
Abstract
Patients with lung cancer experience elevated risk of venous thromboembolism. Cancer patients with thrombosis have a shorter life expectancy and the occurrence of VTE worsens the quality of life and may delay, interrupt, or completely halt the cancer therapy. In a large cohort of lung cancer patients we monitored the incidence of venous thromboembolism and we identified groups of patients with the highest risk of venous thromboembolism suitable for antithrombotic prophylaxis, which could favourably affect their morbidity and mortality.Keywords
This publication has 45 references indexed in Scilit:
- D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancerAnnals of Oncology, 2009
- Trousseau's syndrome: multiple definitions and multiple mechanismsBlood, 2007
- Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinomaThorax, 2006
- Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemiaBlood, 2006
- Diagnostic Issues in Thrombophilia: A Laboratory Scientist's ViewSeminars in Thrombosis and Hemostasis, 2005
- The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinomaJournal of Thrombosis and Haemostasis, 2004
- ThrombocytosisNew England Journal of Medicine, 2004
- Cancer-Related Deep Venous Thrombosis: Clinical Importance, Treatment Challenges, and Management StrategiesSeminars in Thrombosis and Hemostasis, 2003
- Prognostic significance of plasma D-dimer levels in patients with lung cancerThorax, 1997
- Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissuesCancer, 1991